PharmaSGP Holding SE (ETR: PSG)
Germany
· Delayed Price · Currency is EUR 26.20
-0.20 (-0.76%)
Jan 8, 2025, 5:35 PM CET
PharmaSGP Holding SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 114 | 101.1 | 85.82 | 65.34 | 63.25 | 62.57 | Upgrade
|
| Revenue Growth (YoY) | 16.86% | 17.80% | 31.34% | 3.32% | 1.07% | 3.27% | Upgrade
|
| Cost of Revenue | 10.33 | 9.46 | 9.03 | 6.49 | 6.21 | 5.87 | Upgrade
|
| Gross Profit | 103.67 | 91.64 | 76.79 | 58.86 | 57.04 | 56.71 | Upgrade
|
| Selling, General & Admin | 58.1 | 50.72 | 44.29 | 35.53 | 35.42 | 29.87 | Upgrade
|
| Other Operating Expenses | 9.41 | 6.91 | 5.57 | 4.83 | 5.64 | 4.08 | Upgrade
|
| Operating Expenses | 76.84 | 66.92 | 59.05 | 43.83 | 41.54 | 34.34 | Upgrade
|
| Operating Income | 26.83 | 24.71 | 17.75 | 15.02 | 15.5 | 22.36 | Upgrade
|
| Interest Expense | -4.24 | -4.41 | -2.01 | -0.64 | -0.1 | -0.18 | Upgrade
|
| Interest & Investment Income | 1.14 | 0.24 | 0.05 | - | 0.01 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.43 | 1.43 | 0.08 | -0.07 | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | 25.16 | 21.97 | 15.87 | 14.31 | 15.4 | 22.21 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.06 | Upgrade
|
| Asset Writedown | -0.08 | -0.08 | -0.06 | -0.11 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -1.25 | - | Upgrade
|
| Pretax Income | 25.09 | 21.89 | 15.8 | 14.21 | 14.15 | 22.26 | Upgrade
|
| Income Tax Expense | 6.29 | 5.5 | 3.85 | 3.52 | 3.51 | 5.56 | Upgrade
|
| Net Income | 18.8 | 16.4 | 11.95 | 10.69 | 10.64 | 16.71 | Upgrade
|
| Net Income to Common | 18.8 | 16.4 | 11.95 | 10.69 | 10.64 | 16.71 | Upgrade
|
| Net Income Growth | 25.40% | 37.17% | 11.82% | 0.47% | -36.31% | 13.39% | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | -0.36% | -0.06% | - | - | - | - | Upgrade
|
| EPS (Basic) | 1.57 | 1.37 | 1.00 | 0.89 | 0.89 | 1.39 | Upgrade
|
| EPS (Diluted) | 1.57 | 1.37 | 1.00 | 0.89 | 0.89 | 1.39 | Upgrade
|
| EPS Growth | 25.86% | 37.25% | 11.82% | 0.47% | -36.31% | - | Upgrade
|
| Free Cash Flow | 30.07 | 26.59 | 24.59 | 12.15 | 15.04 | 17.63 | Upgrade
|
| Free Cash Flow Per Share | 2.51 | 2.22 | 2.05 | 1.01 | 1.25 | 1.47 | Upgrade
|
| Dividend Per Share | 1.360 | 1.360 | 0.490 | 0.450 | - | - | Upgrade
|
| Dividend Growth | 177.55% | 177.55% | 8.89% | - | - | - | Upgrade
|
| Gross Margin | 90.94% | 90.64% | 89.48% | 90.07% | 90.19% | 90.62% | Upgrade
|
| Operating Margin | 23.54% | 24.44% | 20.68% | 22.99% | 24.51% | 35.74% | Upgrade
|
| Profit Margin | 16.49% | 16.22% | 13.93% | 16.36% | 16.82% | 26.70% | Upgrade
|
| Free Cash Flow Margin | 26.37% | 26.30% | 28.66% | 18.59% | 23.78% | 28.18% | Upgrade
|
| EBITDA | 35.53 | 33.38 | 26.37 | 18.08 | 15.67 | 22.38 | Upgrade
|
| EBITDA Margin | 31.16% | 33.02% | 30.72% | 27.67% | 24.77% | 35.76% | Upgrade
|
| D&A For EBITDA | 8.7 | 8.67 | 8.62 | 3.06 | 0.17 | 0.02 | Upgrade
|
| EBIT | 26.83 | 24.71 | 17.75 | 15.02 | 15.5 | 22.36 | Upgrade
|
| EBIT Margin | 23.54% | 24.44% | 20.68% | 22.99% | 24.51% | 35.74% | Upgrade
|
| Effective Tax Rate | 25.06% | 25.10% | 24.36% | 24.75% | 24.80% | 24.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.